INS and breast carcinoma: Moreover, PAPP-A has proteolytic activity targeting insulin-like growth factors binding proteins, which increases concentrations of free insulin-like growth factors [15], [16] and both PAPP-A and insulin-like growth factors are associated with breast cancer development and progression [17], [18].